Original paper
Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study
Abstract
The genes regulating circulating levels of soluble gp130 (sgp130), the antagonist of the inflammatory response in atherosclerosis driven by interleukin 6, are largely unknown. Aims of the present study were to identify genetic loci associated with circulating sgp130 and to explore the potential association between variants associated with sgp130 and markers of subclinical atherosclerosis. The study is based on IMPROVE ( n = 3703), a...
Paper Details
Title
Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study
Published Date
Jan 14, 2020
Journal
Volume
21
Issue
2
Pages
100 - 108
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History